Starling Oncology STLN
NASDAQ STLN
$6.48 -0.03 (-0.46%)
As of: Sep 30, 2026 · 2:32 PM EDT

Starling Oncology (STLN) Capital Expenditures (2021 - 2026)

Updated

Starling Oncology (STLN) reported Capital Expenditures of $908,000 for Q2 2026, down 24.8% from $1.21 million a year earlier and down 12.9% from the prior quarter.

Analysis

Starling Oncology (STLN) Capital Expenditures (2021 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Starling Oncology's Capital Expenditures came in at $3.61 million, up 25.1% year-over-year; for FY2025, it was $3.2 million, down 15.5% from FY2024.

  • Capital Expenditures has declined for three consecutive years, though with a five-year compound annual growth rate of 21.8% (FY2020 to FY2025).
  • By year, Capital Expenditures came in at $3.79 million in FY2024 (-17.0%), $4.57 million in FY2023 (-17.4%), $5.53 million in FY2022 (+94.2%) and $2.85 million in FY2021 (+138.4%).
  • Five-year quarterly Capital Expenditures spans a low of -$402,000 in Q3 2024 and a high of $2 million in Q4 2022.
  • Year over year, Capital Expenditures gained in two of the last six quarters, with growth averaging 29.5%.
  • The high point for year-over-year Capital Expenditures in five years was Q2 2022 (growth of 229.7%); the low point was Q1 2024 (a decline of 66.8%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.04 million (Q1 2026), $1.06 million (Q4 2025) and $604,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 HCA Healthcare 94.08 Bn 93.52 Bn - 1.23 Bn
2 Natera 59.53 Bn 55.21 Bn 485.19 Mn 63.43 Mn
3 Quest Diagnostics 25.60 Bn 24.03 Bn 1.03 Bn 138.00 Mn
4 Labcorp Holdings 24.98 Bn 22.75 Bn 1.11 Bn 131.60 Mn
5 Guardant Health 23.75 Bn 19.81 Bn 219.03 Mn 11.76 Mn
6 Tenet Healthcare 20.75 Bn 11.90 Bn - 168.00 Mn
7 Tempus AI 14.47 Bn 11.50 Bn 246.50 Mn 6.13 Mn
8 Encompass Health 12.19 Bn 12.65 Bn - 220.30 Mn
9 Davita 11.20 Bn 9.97 Bn 1.16 Bn 169.82 Mn
10 Starling Oncology 654.05 Mn 521.46 Mn 27.17 Mn 908,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 908,000.00
Mar 31, 2026 1.04 Mn
Dec 31, 2025 1.06 Mn
Sep 30, 2025 604,000.00
Jun 30, 2025 1.21 Mn
Mar 31, 2025 328,000.00
Dec 31, 2024 1.76 Mn
Sep 30, 2024 -402,000.00
Jun 30, 2024 1.83 Mn
Mar 31, 2024 610,000.00
Dec 31, 2023 861,000.00
Sep 30, 2023 930,000.00
Jun 30, 2023 937,000.00
Mar 31, 2023 1.84 Mn
Dec 31, 2022 2.00 Mn
Sep 30, 2022 1.19 Mn
Jun 30, 2022 1.34 Mn
Mar 31, 2022 1.00 Mn
Dec 31, 2021 871,000.00
Sep 30, 2021 950,000.00
API Access

Starling Oncology Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=STLN&period=max&api_key=YOUR_API_KEY